DelphX Capital Markets Grants 950,000 Stock Options to Boost Market Position

DelphX Capital Markets ( (TSE:DELX) ) just unveiled an update.

DelphX Capital Markets Inc. has announced the approval of 950,000 stock options by its Board of Directors, granted to eligible participants under its stock option plan. These options, with a two-year maturity and an exercise price of $0.20 per common share, are part of DelphX’s strategic efforts to enhance its market position and incentivize stakeholders. This move reflects DelphX’s commitment to innovation in the fixed income market and could potentially strengthen its competitive edge by aligning the interests of its participants with the company’s growth objectives.

More about DelphX Capital Markets

DelphX Capital Markets Inc. is a technology and financial services company that focuses on developing and distributing innovative structured products for the fixed income market. Through its special purpose vehicle, Quantem LLC, DelphX enables fixed income dealers to offer private placement securities that mitigate spread and capital charge losses during downgrades, while providing attractive returns. Their proprietary products include collateralized put options (CPOs) and collateralized reference notes (CRNs), which are fully collateralized and held in custody by BNY Mellon.

YTD Price Performance: -20.0%

Average Trading Volume: 5,665

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: $12.33M

For detailed information about DELX stock, go to TipRanks’ Stock Analysis page.